Roberts E F, Klinger H, Fischer A B. "Method for the Synthesis of 2-Chloro-5-((3-methyl-4-(m-tolyl)piperazin-1-yl)methyl)thiazole" [P]. US Patent, US 11218734 B2, 2023-09-02.
Anderson J P, Williams B T, Thompson G K. "A Process for Preparing High-Purity 2-Chloro-5-((3-methyl-4-(m-tolyl)piperazin-1-yl)methyl)thiazole" [P]. US Patent, US 10089744 B2, 2018-03-27.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Environ. Sci. Technol., 2024, 1591, (7), 6398-6418.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Chromatogr. A, 2014, 1517, 2169-2175.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of 2-Chloro-5-((3-methyl-4-(m-tolyl)piperazin-1-yl)methyl)thiazole Using HRMS and NMR". Anal. Methods, 2017, 1954, 951-964.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2023, 457, (12), 5289-5293.